CA2144441A1 - Dexpanthenol-containing plaster for the transdermal application of steroid hormones - Google Patents

Dexpanthenol-containing plaster for the transdermal application of steroid hormones

Info

Publication number
CA2144441A1
CA2144441A1 CA002144441A CA2144441A CA2144441A1 CA 2144441 A1 CA2144441 A1 CA 2144441A1 CA 002144441 A CA002144441 A CA 002144441A CA 2144441 A CA2144441 A CA 2144441A CA 2144441 A1 CA2144441 A1 CA 2144441A1
Authority
CA
Canada
Prior art keywords
dexpanthenol
steroid hormones
transdermal application
plaster
containing plaster
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002144441A
Other languages
French (fr)
Other versions
CA2144441C (en
Inventor
Michael Roreger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4230588A external-priority patent/DE4230588C1/en
Application filed by Individual filed Critical Individual
Publication of CA2144441A1 publication Critical patent/CA2144441A1/en
Application granted granted Critical
Publication of CA2144441C publication Critical patent/CA2144441C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A self adhesive plaster for the transdermal application of steroid hormones with a backing impermeable to active agents, an adhesive layer containing the active agent and a protective layer removable before the application of the plaster to the skin, in which the active agent-containing adhesive layer contains a hot-melt adhesive with a processing temperature of between 60 and 100°C and dexpanthenol in a concentration of 15 to 25 wt.%.
CA002144441A 1992-09-12 1993-08-16 Dexpanthenol-containing plaster for the transdermal application of steroid hormones Expired - Lifetime CA2144441C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEP4230588.8 1992-09-12
DE4230588A DE4230588C1 (en) 1992-09-12 1992-09-12 Dexpanthenol-containing plaster for the transdermal application of steroid hormones and process for its production
PCT/EP1993/002182 WO1994006436A1 (en) 1992-09-12 1993-08-16 Dexpanthenol-containing plaster for the transdermal application of steroid hormones

Publications (2)

Publication Number Publication Date
CA2144441A1 true CA2144441A1 (en) 1994-03-31
CA2144441C CA2144441C (en) 2005-10-25

Family

ID=35311573

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002144441A Expired - Lifetime CA2144441C (en) 1992-09-12 1993-08-16 Dexpanthenol-containing plaster for the transdermal application of steroid hormones

Country Status (1)

Country Link
CA (1) CA2144441C (en)

Also Published As

Publication number Publication date
CA2144441C (en) 2005-10-25

Similar Documents

Publication Publication Date Title
IL106512A (en) Plaster for the transdermal application of steroid hormones and process for the preparation thereof
CA2045290A1 (en) Plaster with a high content of softening ingredients
ATA87488A (en) MULTI-LAYER TRANSDERMAL THERAPEUTIC SYSTEM FOR THE COMBINED APPLICATION OF OESTROGEN OR. SYNTHETIC EESTROGEN-ACTIVE COMPOUNDS WITH SYNTHETIC GESTAGENS
CA2010218A1 (en) Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances
MY100066A (en) Multicompartmentalized dermal and transdermal patches.
EP0164998A3 (en) Compositions and methods of enhancing transdermal and transmembrane penetration of topical and systemic agents
CA2120599A1 (en) Transdermal therapeutic systems containing crystallization inhibitors
NO884530D0 (en) PLACES WITH ACTIVE SUBSTANCES FOR CONTROLLED ACTIVE SUBSTANCES TO THE SKIN, USING SAAVEL AS THE PROCEDURE FOR CONTROLLED ACTIVE SUBSTANCES TO THE SKIN.
MY111126A (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid.
WO1997004818A3 (en) Transdermal therapeutic sysgtem for administering active agents to the human body via the skin
IE873120L (en) User-activated transdermal therapeutic system
WO1990001915A3 (en) Adhesive dressings
AU4739089A (en) Superficial therapeutic system comprising an anti-neoplastic active substance, particularly 5-fluorouracil
CA2144441A1 (en) Dexpanthenol-containing plaster for the transdermal application of steroid hormones
CA2384739A1 (en) Plastic films, especially for use in a dermal or transdermal therapeutic system
WO1997021430A3 (en) Surface-stabilised pharmaceutical preparation for application on the skin
WO1996008237A3 (en) Pressure-sensitive adhesive plaster for releasing active substance into the environment of a support
IL114948A (en) Transdermal therapeutic system containing estradiol and process for the preparation thereof
PL308531A1 (en) Percutaneous therapeutic system for applying physostygmine onto skin and method of obtaining same
AU6879887A (en) Dermal and transdermal patches having a discontinuous pattern adhesive layer
MX9705291A (en) Plaster containing estradiol.
MX9704291A (en) Transdermal delivery system with adhesive overlay and peel seal disc.

Legal Events

Date Code Title Description
EEER Examination request
MKEC Expiry (correction)

Effective date: 20131009